PMX #

Related by string. * : PMX # PolyMedix . PMX . antibiotic compound PMX . PMX Gold . NYSE PMX . PMX Industries . NYSE PMX PIMCO / # [012] . # [007] . # [016] . #s [002] . # [014] . #s [004] . # [004] : #.# ov #-# . ID # # . #-#:# pm [001] . i Newswire #-#-# . Call #-#-# [002] . #-#-# ATS [003] . #-#-# ATS [002] * PMX # PolyMedix heptagonist . PMX # antibiotic . PMX # heptagonist . PMX # reverse . compound PMX # *

Related by context. Frequent words. (Click for all words.) 61 RDEA# 60 antiviral activity 60 pharmacokinetic profile 60 Phase 1b 59 CBLB# 59 HspE7 58 MGCD# [001] 58 CYT# 58 Phase 2a 58 oral dosing 58 Phase Ib 57 ISIS # 57 pharmacokinetic 57 dose escalation 57 voreloxin 57 JANUVIA 56 tolerability profile 56 tolerability 56 bavituximab 56 dosing regimens 56 IMGN# 56 antitumor activity 55 mg dose 55 LEVADEX 55 sitagliptin 55 AP# [003] 55 Phase 2a clinical 55 Preclinical studies 55 Phase 2b study 55 ANA# 54 Marqibo 54 preclinical studies 54 Phase IIa trial 54 pharmacodynamic 54 administered orally 54 INCB# [002] 54 pharmacodynamics 54 Phase IIb trial 53 Phase 2b trial 53 dose escalation study 53 CRx 53 ALKS 53 dosing regimen 53 pharmacokinetics 53 orally administered 53 dasatinib 53 PRX # 52 SPRYCEL 52 RG# [001] 52 sunitinib 52 TMC# [001] 52 monotherapy 52 docetaxel 52 hematologic malignancies 52 picoplatin 52 prodrug 52 tivozanib 52 IDX# 52 immunogenicity 52 Phase IIa 52 plasma concentrations 51 pivotal Phase 51 mg doses 51 Vidaza 51 Phase III clinical trials 51 Locteron 51 sirolimus 51 MGCD# [002] 51 investigational drug 51 vitro studies 51 VELCADE 51 clinically meaningful 51 cytotoxic 51 certolizumab pegol 51 G CSF 51 Phase 2b clinical 50 etanercept 50 AEZS 50 receptor antagonist 50 ADX# 50 anti angiogenic 50 Phase IIa clinical 50 clinically relevant 50 pivotal Phase III 50 perifosine 50 AZD# 50 cytotoxicity 50 ofatumumab 50 dosing 50 ACTEMRA 50 Clolar 50 APD# 50 telbivudine 50 Phase IIb 50 protease inhibitor 49 CK # 49 Bronchitol 49 ENBREL 49 bortezomib 49 FOLOTYN 49 investigational compound

Back to home page